BIOCOM Board of Directors

Chair:

Randall E. Woods, Sequel Pharmaceuticals

Vice Chair:

M. Wainwright Fishburn, Jr., Cooley Godward Kronish LLP

Chair Elect:

Dan Bradbury, Amylin Pharmaceuticals

Emeritus:

Greg Lucier, Life Technologies

Vice President and General Counsel:

Stephen Ferruolo, J.D., Ph.D., Goodwin Procter LLP

Vice President – Finance:

Theresa Drew, Deloitte

Vice President and Secretary:

Kennon W. Baldwin, Ferguson Pape Baldwin Architects

Vice President – Industry:

Alexis Lukianov, NuVasive, Inc.

President and CEO:

Joseph D. Panetta, BIOCOM

Jack Lief, Arena Pharmaceuticals, Inc.
David Marino, Irving Hughes
Steven J. Mento, Ph.D., Conatus Pharmaceuticals, Inc.
Tina Nova, Genoptix
Trindl Reeves, Barney & Barney LLC
Larry Stambaugh, Apercu Consulting
Kleanthis G. Xanthopoulos, Ph.D., Regulus Therapeutics

Life Directors:

David Hale, Somaxon Pharmaceuticals
William Rastetter, Venrock Associates
Duane J. Roth, CONNECT

Life Sciences Industry Sector:

Vince Anido, Ph.D., ISTA Pharmaceuticals
Rex Bright, SkinMedica, Inc.
Terrance J. Bruggeman, Geneve Bio, Inc.
Bernd Brust, Life Technologies
Daniel Burgess, Mpex Pharmaceuticals, Inc.
John M. Dunn, Biogen Idec, Inc .
Steven B. Engle, Xoma LLC
Carl Hull, Gen-Probe, Inc.
John Hurrell, Ph.D., Focus Diagnostics
Catherine Mackey, Ph.D., Pfizer La Jolla
Magda Marquet, Ph.D., AltheaDx
Elliot Parks, Ph.D., Hawaii Biotechnology Group
Scott Salka, Ambit Biosciences
James Schaeffer, Ph.D., Merck Research Laboratories
Jackson Streeter, M.D., PhotoThera, Inc.
Roger Stoll, Ph.D., Cortex Pharmaceuticals
David Webb, Ph.D., Celgene
Gerald Yakatan, Ph.D., IriSys
Tony Yost, Novartis

Associate and Academic Members Sector:

Susan Bryant, Ph.D., UC Irvine
David Brenner, M.D. UCSD Health Sciences
Carin Canale, Porter Novelli Life Sciences
Constance Carroll, Ph.D., San Diego Community College District
Larry Cohn, Stradling Yocca Carlson & Rauth
Scott Foote, Square 1 Bank
Milton Gordon, Ph.D., California State University, Fullerton
Jeffrey W. Guise, Ph.D., Wilson, Sonsini, Goodrich & Rosati
Lisa A. Haile, J.D., Ph.D., DLA Piper
Guy J. Iannuzzi, Mentus, Inc.
Brent D. Jacobs, Cushman & Wakefield
Richard Kaufman, Foley & Lardner LLP
Daniel Kleeburg, Ernst & Young
Mary E. Lyons, Ph.D., University of San Diego
Susan Nowakowski, AMN Healthcare Services
John C. Reed, M.D., Ph.D., Burnham Institute for Medical Research
Theodore D. Roth, Roth Capital Partners LLC
Drew Senyei, M.D., Enterprise Partners Venture Capital
Stephen Weber, Ph.D., San Diego State University
Scott N. Wolfe, Latham & Watkins LLP

BIOCOM Board Members-Ex-Officio:

Gary Friedman, Esq., The Agouron Institute
Julie Meier Wright, San Diego Regional EDC
Peter Preuss, The Preuss Foundation
Bob Sullivan, Ph.D., UCSD Rady School of Management